These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9459451)

  • 1. Glutamate receptor GluR3 antibodies and death of cortical cells.
    He XP; Patel M; Whitney KD; Janumpalli S; Tenner A; McNamara JO
    Neuron; 1998 Jan; 20(1):153-63. PubMed ID: 9459451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.
    Rogers SW; Andrews PI; Gahring LC; Whisenand T; Cauley K; Crain B; Hughes TE; Heinemann SF; McNamara JO
    Science; 1994 Jul; 265(5172):648-51. PubMed ID: 8036512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins.
    Whitney KD; McNamara JO
    J Neurosci; 2000 Oct; 20(19):7307-16. PubMed ID: 11007888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rasmussen's encephalitis with concomitant cortical dysplasia: the role of GluR3.
    Palmer CA; Geyer JD; Keating JM; Gilliam F; Kuzniecky RI; Morawetz RB; Bebin EM
    Epilepsia; 1999 Feb; 40(2):242-7. PubMed ID: 9952274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel.
    Levite M; Fleidervish IA; Schwarz A; Pelled D; Futerman AH
    J Autoimmun; 1999 Aug; 13(1):61-72. PubMed ID: 10441169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis.
    Whitney KD; Andrews PI; McNamara JO
    Neurology; 1999 Sep; 53(4):699-708. PubMed ID: 10489029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor GluR3.
    Krauss GL; Campbell ML; Roche KW; Huganir RL; Niedermeyer E
    Neurology; 1996 Jan; 46(1):247-9. PubMed ID: 8559386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies prepared to neuronal glutamate receptor subunit3 bind IFNalpha-receptors: implications for an autoimmune process.
    Gahring LC; Carlson NG; Rogers SW
    Autoimmunity; 1998; 28(4):243-8. PubMed ID: 9892506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy.
    Ganor Y; Goldberg-Stern H; Amrom D; Lerman-Sagie T; Teichberg VI; Pelled D; Futerman AH; Zeev BB; Freilinger M; Verheulpen D; Van Bogaert P; Levite M
    Clin Dev Immunol; 2004; 11(3-4):241-52. PubMed ID: 15559370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis?
    Levite M; Hermelin A
    J Autoimmun; 1999 Aug; 13(1):73-82. PubMed ID: 10441170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures.
    Mantegazza R; Bernasconi P; Baggi F; Spreafico R; Ragona F; Antozzi C; Bernardi G; Granata T
    J Neuroimmunol; 2002 Oct; 131(1-2):179-85. PubMed ID: 12458050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis.
    Levite M; Ganor Y
    Expert Rev Neurother; 2008 Jul; 8(7):1141-60. PubMed ID: 18590483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site.
    Twyman RE; Gahring LC; Spiess J; Rogers SW
    Neuron; 1995 Apr; 14(4):755-62. PubMed ID: 7718238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
    Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
    J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
    Watson R; Jiang Y; Bermudez I; Houlihan L; Clover L; McKnight K; Cross JH; Hart IK; Roubertie A; Valmier J; Hart Y; Palace J; Beeson D; Vincent A; Lang B
    Neurology; 2004 Jul; 63(1):43-50. PubMed ID: 15249609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rasmussen's encephalitis: an autoimmune disorder?
    Andrews PI; McNamara JO
    Curr Opin Neurobiol; 1996 Oct; 6(5):673-8. PubMed ID: 8937833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate receptor subunit 3 (GluR3) immunoreactivity delineates a subpopulation of parvalbumin-containing interneurons in the rat hippocampus.
    Moga DE; Janssen WG; Vissavajjhala P; Czelusniak SM; Moran TM; Hof PR; Morrison JH
    J Comp Neurol; 2003 Jul; 462(1):15-28. PubMed ID: 12761821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labeling of rat neurons by anti-GluR3 IgG from patients with Rasmussen encephalitis.
    Frassoni C; Spreafico R; Franceschetti S; Aurisano N; Bernasconi P; Garbelli R; Antozzi C; Taverna S; Granata T; Mantegazza R
    Neurology; 2001 Jul; 57(2):324-7. PubMed ID: 11468321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity to munc-18 in Rasmussen's encephalitis.
    Yang R; Puranam RS; Butler LS; Qian WH; He XP; Moyer MB; Blackburn K; Andrews PI; McNamara JO
    Neuron; 2000 Nov; 28(2):375-83. PubMed ID: 11144349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.